Imunon, Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of Imunon, Inc.'s 2024 Annual Meeting of Stockholders held on June 12, 2024. The filing was submitted on June 13, 2024. The company is incorporated in Delaware and its common stock trades on the Nasdaq Capital Market under the symbol IMNN.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance actions and voting results rather than financial performance data.
Material Changes and Voting Results
The following actions were taken at the Annual Meeting:
- Proposal 1 (Election of Directors): Dr. Stacy R. Lindborg and James E. Dentzer were elected to the Board of Directors to serve until the 2027 Annual Meeting. Frederick J. Fritz, Christine A. Pellizzari, Dr. Donald P. Braun, and Michael H. Tardugno continued to serve as directors.
- Proposal 2 (Ratification of Auditors): Stockholders approved the appointment of WithumSmith + Brown, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
- Proposal 3 (Say-on-Pay): Stockholders approved, on an advisory basis, the 2023 compensation of the Company's named executive officers.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document serves as a record of shareholder votes.
Key Facts for Investor Verification
- Verify the total number of shares entitled to vote and the quorum status at the June 12, 2024 meeting.
- Confirm the specific vote counts for the "Say-on-Pay" proposal, noting the significant number of abstentions (400,735) and broker non-votes (1,935,151).
- Review the definitive proxy statement dated April 26, 2024, for detailed biographies of the newly elected directors and the rationale for the auditor appointment.
- Check subsequent filings for the company's actual financial performance, as this 8-K contains no financial data.